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Listeria monocytogenes is a gram-positive bacterial pathogen that multiplies in the cytosol of host cells and 
spreads directly from cell to cell. During cell-to-cell spread, bacteria become temporarily conﬁned to secondary 
vacuoles. The broad-range phospholipase C (PC-PLC) of L. monocytogenes contributes to bacterial escape from 
secondary vacuoles. PC-PLC requires cleavage of an N-terminal propeptide for activation, and Mpl, a metal­
loprotease of Listeria, is involved in the proteolytic activation of PC-PLC. Previously, we showed that cell wall 
translocation of PC-PLC is inefﬁcient, resulting in accumulation of PC-PLC at the membrane-cell wall 
interface. In infected cells, rapid cell wall translocation of PC-PLC is triggered by a decrease in pH and 
correlates with cleavage of the propeptide in an Mpl-dependent manner. To address the role of the propeptide 
and of Mpl in cell wall translocation of PC-PLC, we generated a cleavage site mutant and a propeptide deletion 
mutant. The intracellular behavior of these mutants was assessed in pulse-chase experiments. We observed 
efﬁcient translocation of the proform of the PC-PLC cleavage site mutant in a manner that was pH sensitive 
and Mpl dependent. However, the propeptide deletion mutant was efﬁciently translocated into host cells 
independent of Mpl and pH. Overall, these results suggest that Mpl regulates PC-PLC translocation across the 
bacterial cell wall in a manner that is dependent on the presence of the propeptide but independent of 
propeptide cleavage. In addition, similarly to Mpl-mediated cleavage of PC-PLC propeptide, Mpl-mediated 
translocation of PC-PLC across the bacterial cell wall is pH sensitive. 
Listeria monocytogenes is an opportunistic bacterial patho­
gen that has the ability to multiply in the cytosol of eukaryotic 
cells (9, 32) and spread to neighboring cells without entering 
the extracellular milieu. Successful infection by L. monocyto­
genes is dependent on the bacterium’s ability to escape mem­
brane vacuoles formed upon initial entry into a host cell and 
upon direct cell-to-cell spread. Among the factors involved in 
bacterial escape from these vacuoles is a secreted broad-range 
phospholipase C (PC-PLC) (Fig. 1a) (28, 34), whose activity 
requires proteolytic cleavage of a 24-amino-acid N-terminal 
propeptide (24, 25). A metalloprotease of L. monocytogenes 
(Mpl) is associated with the proteolytic activation of PC-PLC 
(19, 25). During intracellular infection, PC-PLC activation is 
dependent on cell-to-cell spread and vacuolar acidiﬁcation 
(19), indicating that cleavage of the propeptide occurs specif­
ically in acidiﬁed vacuoles. We are interested in deﬁning the 
mechanism regulating PC-PLC activity during intracellular in­
fection. 
A number of prokaryotic and eukaryotic proteins are syn­
thesized as preproproteins, in which the signal peptide is fol­
lowed by a propeptide whose proteolytic cleavage is required 
to generate the mature protein (5, 27). There are two classes of 
propeptides, class I and II. Class I propeptides generally func­
tion as intramolecular chaperones, facilitating folding of the 
mature protein. In some instances the propeptide can function 
in trans, but native conformation cannot be reached without 
the propeptide (21, 36). Class I propeptides are primarily as­
sociated with proteases. Class II propeptides exert their bio­
logical function by a variety of mechanisms, including oli­
gomerization, intermolecular interactions, maturation, sorting, 
folding, and secretion (27). Among others are the propeptide 
of Bacillus amyloliquefaciens small RNase barnase, which de­
creases the rate of protein folding in the presence of GroEL 
(11), the propeptides of Staphylococcus aureus nuclease and of 
Rhizopus oryzae lipase, which increase the rate of protein fold­
ing and secretion (3, 17), and that of human myeloperoxidase, 
which is required for the maturation process and sorting of the 
protein to azurophil granules of neutrophils (1). 
Studies have shown that processing of the PC-PLC propep­
tide is a prerequisite to enzymatic activity (25), but the mech­
anism by which the propeptide prevents activity is unknown. 
The propeptide could interact with the phospholipase active 
site or interfere with folding of the catalytic domain. In a 
recent study, we showed that the proform of PC-PLC does not 
translocate very efﬁciently across the bacterial cell wall and 
that processing of the PC-PLC propeptide correlates with a 
rapid increase in the rate of PC-PLC translocation (20, 30). 
This observation is consistent with a role of the propeptide in 
protein folding, as there are examples of proteins whose rate of 
folding correlates with their rate of translocation across the cell 
wall (14, 33, 35). Alternatively, intermolecular interactions in­
volving the prodomain could prevent translocation of PC-PLC 
across the cell wall. 
Mpl is predicted to be a 55-kDa secreted protein composed 
of a 20-kDa propeptide and a 35-kDa catalytic domain (22). 
Like PC-PLC, Mpl is bacterium associated and secreted (30). 
In infected mammalian cells, rapid translocation of bacterium­
 
   
FIG. 1. Schematic diagrams of L. monocytogenes PC-PLC. (a) PC-PLC is translated as a preproprotein. The proform of PC-PLC encompasses 
the propeptide and the catalytic domain. The pro and active forms of PC-PLC have calculated molecular masses of 30.4 and 27.7 kDa but run as 
33- and 28-kDa species on SDS-PAGE. (b) The amino acid sequence of the propeptide is ﬂanked by partial amino acid sequence of the signal 
peptide and catalytic domain. The Mpl cleavage site is indicated for the wild-type strain. For the PC-PLC S51D S53N mutant, two amino acid 
residues are mutated, decreasing the efﬁciency of Mpl cleavage. The PC-PLC�pro mutant was generated by deletion of the entire propeptide. 
associated PC-PLC is triggered by a decrease in pH in an 
Mpl-dependent manner. Therefore, Mpl-mediated processing 
of the PC-PLC propeptide might control translocation of PC­
PLC across the bacterial cell wall. Alternatively, Mpl may tar­
get secondary molecules whose processing or degradation is 
the prerequisite to the efﬁcient translocation of PC-PLC across 
the cell wall. Moreover, Mpl may carry a dual function as a 
chaperone and a protease contributing to PC-PLC folding and 
proteolytic activation. DegP, also known as HtrA, is a good 
example of a bacterial extracytoplasmic protein carrying such a 
dual function (2, 15, 31). 
The present study investigates the role of the PC-PLC 
propeptide and of Mpl in the mechanism regulating translo­
cation of PC-PLC across the bacterial cell wall. To address this 
point, we created a PC-PLC cleavage site mutant (PC-PLC 
S51D S53N) and a prodomain deletion mutant (PC-PLC� 
pro). The intracellular behaviors of the mutated PC-PLC pro­
teins as a function of pH and of Mpl were investigated. Our 
results indicate that Mpl contributes to the translocation of 
PC-PLC independently of cleavage of the propeptide and that, 
in absence of the propeptide, PC-PLC translocation across the 
bacterial cell wall is no longer regulated by Mpl and pH. 
MATERIALS AND METHODS 
Bacterial strains and culture conditions. Bacterial strains and relevant geno­
types are listed in Table 1. For the in vitro experiments, expression of the 
PrfA-regulated genes was induced by growing bacteria in Luria-Bertani (LB) 
broth with 50 mM morpholinepropanesulfonic acid (MOPS) adjusted to pH 7.3, 
25 mM glucose-1-phosphate (G1P), and 0.2% activated charcoal (LB-MOPS­
G1P) (26, 30). For J774 infections, bacteria were grown overnight at 30°C in 
brain heart infusion broth. 
Construction of plcB�pro. An internal in-frame deletion was created in the 
plcB gene to delete the propeptide coding sequence (Fig. 1b). A 672-bp fragment 
containing the 5� end of the plcB gene (coding for the signal sequence) and 
upstream region was ampliﬁed by PCR with primers Marq-46 and Marq-123 
(Table 2), using 10403S genomic DNA as a template. A second fragment of 1,300 
bp containing sequence coding for the catalytic domain of PC-PLC and down­
stream sequence was ampliﬁed by PCR with primers Marq-124 and Marq-107 
(Table 2). PCR fragments were puriﬁed, digested with AvaIII, and ligated. 
Ligation product was used as template for PCR ampliﬁcation of plcB�pro using 
ﬂanking primers Marq-46 and Marq-107. The resulting product (1,938 bp) was 
digested with HindIII and XbaI and cloned into the shuttle vector pKSV7 (29), 
creating pHEL-332. pHEL-332 was electroporated into strains 10403S and the 
�mpl mutant (DP-L2296), and the mutation was introduced into the chromo­
some of these strains by allelic exchange as previously described (6), creating 
HEL-335 and HEL-333 (Table 1). 
Construction of plcB cleavage site mutant. The plcB cleavage site mutant was 
generated by random mutagenesis. As described in more detail below, a degen­
erate primer with the sequence RRYTGGRRY was used, which would put one 
of four amino acids (D, N, S, and G) at S51 and S53 of the plcB open reading 
frame. D, N, and G are not generally favorable for protease activity of the Mpl 
family (23). 
TABLE 1. L. monocytogenes strains and genotypes 
Strain Genotypea Source of strain or reference 
10403S Wild type 4 
DP-L1935 �plcB 28 
DP-L2296 �mpl 18 
DP-L2787 
DP-L3525 
�plcB �mpl 
�(plcB�-plc�)b 
19 
38 
HEL-333 plcB�pro �mpl This study 
HEL-335 plcB�pro This study 
HEL-337 plcB S51D S53N This study 
HEL-338 plcB S51D S53N �mpl This study 
a All mutants are derivatives of 10403S. 
b Gene fusion of L. monocytogenes prepro-PC-PLC plcB sequence and B. 
cereus catalytic domain of plc sequence. 
TABLE 2. Oligonucleotide primers used in this study 
Marq no. Nucleotide sequence (5�-3�) with underlined restriction sites Characteristics 
46 AATAAGCGCACCAAGCTTGATAAGTGACATAACTA 5� plcB HindIII fwd 
101 CCACATAAGCTTRRYTGGRRYGCGGATAAC 5� plcB cleavage HindIII fwd 
102 GCGGACCAACTAAGCTTATGGGGTAATTTGCTG 3� plcB propeptide HindIII rev 
105 GGTGAATGTCATGAAGTTCAAAAAGGTGGTT 5� plcB signal peptide BspHI fwd 
106 CTAGCTGCAGCTTTTCCATGGGTTTCACTCTCC 3� hly P NcoI rev 
107 TTACATCTAGAACTGCGGTACCCTTTT 3� plcB XbaI and KpnI rev 
122 TTTAAAGAATTCGGATCCTGGTAAATGTTGAG 5� hly P BamHI fwd 
123 GTAAGTATGGATCCCAACATGCATTTGCTTTTA plcB �pro AvaIII rev 
124 CCACATAAACATGCATGGTCAGCGGATAAC plcB �pro AvaIII fwd 
151 CACATAAACTTGATTGGAACGCGGATAAC plcB S51D S53N fwd 
152 GTTATCCGCGTTCCAATCAAGTTTATGTG plcB S51D S53N rev 
To construct PC-PLC cleavage site mutants, three separate fragments were 
ampliﬁed by PCR using puriﬁed 10403S genomic DNA as a template. The hly 
promoter region (621 bp) was ampliﬁed with primers Marq-122 and Marq-106 
(Table 2); the 5� end of the plcB gene, containing the signal sequence and 
propeptide (170 bp) was ampliﬁed with primers Marq-105 and Marq-102 (Table 
2); and the 3� end of plcB (1,300 bp) was ampliﬁed with primer Marq-101, which 
contains degenerate codons for the cleavage site mutants, and primer Marq-107 
(Table 2). The hly promoter fragment was digested with BamHI and NcoI, the 
plcB 5� fragment was digested with BspHI and Hind III, and the plcB 3� fragment 
was digested with HindIII and KpnI. All three fragments were sequentially 
ligated together and cloned into pPL2. pPL2 is an L. monocytogenes phage-
speciﬁc integration vector (16). Resulting constructs were conjugated into 
DP-L1935, a �plcB derivative of 10403S, and integrants were screened for chlor­
amphenicol resistance and PC-PLC activity on LB-G1P-EY plates. Chloram­
phenicol-resistant clones showing no or decreased levels of PC-PLC activity were 
selected. The plcB cleavage site region was sequenced from the selected clones, 
and Western immunoblot assays were performed for detection of PC-PLC from 
bacterial supernatants. One mutant was selected for its defect in PC-PLC pro­
cessing: plcB S51D S53N (Fig. 1b). 
The plcB cleavage site mutant was recreated by allelic exchange in wild-type 
strain 10403S and DP-L2296. For this purpose, the construct was generated by 
SOEing PCR and cloned into the shuttle vector pKSV7 as described above for 
the plcB�pro mutants. Primers used for plcB S51D S53N were Marq-46 and 
Marq-152 for the 5� DNA fragment (738 bp) and Marq-151 and Marq-107 for the 
3� DNA fragment (1,299 bp) (Table 2). The construct was sequenced and inte­
grated into the chromosome of L. monocytogenes. Mutant clones were identiﬁed 
by PCR ampliﬁcation of the plcB gene using primers Marq 46 and Marq 107 and 
restriction digest of the PCR product with BsaJ1. Acquisition of the mutation 
correlated with the loss of a BsaJ1 site. 
Detection of phospholipase activity. LB agar was supplemented with 0.2% 
activated charcoal granules before autoclaving. The medium was cooled down to 
55°C before adding glucose-1-phosphate (25 mM), egg yolk (1.25%), and strep­
tomycin (200 �g/ml). LB-G1P-EY plates were poured without the charcoal. 
Inoculated plates were incubated at 37°C, and PC-PLC activity was detected by 
the formation of a zone of opacity in the medium. 
The egg yolk overlay assay was performed as previously described (19). Brieﬂy, 
trichloroacetic acid-concentrated supernatants from LB-MOPS-G1P bacterial 
cultures were fractionated by sodium dodecyl sulfate-polyacrylamide gel electro­
phoresis (SDS-PAGE). After electrophoresis, the gel was washed successively 
with isopropanol and phosphate-buffered saline, overlaid with egg yolk soft agar, 
and incubated at 37°C. PC-PLC activity was detected by the formation of a zone 
of opacity in the overlay. 
Proteolytic digests. To investigate the folding of secreted PC-PLC, bacterial 
culture supernatants were treated with different endopeptidases prior to Western 
immunoblotting. Brieﬂy, L. monocytogenes wild-type and mutant strains were 
grown in LB-MOPS-G1P at 37°C without shaking to an optical density at 600 nm 
of 1.2 to 1.4. Bacterial cells were pelleted by centrifugation at 8,820 � g for 10 
min at 4°C. Supernatants were collected and treated with 200 �g of trypsin/ml for 
15 min at 25°C, 50 �g of chymotrypsin/ml for 15 min at 25°C, 10 �g of thermo­
lysin/ml for 18 h at 37°C, or 2 U of  glutamyl endopeptidase (V8)/ml for 18 h at 
37°C. Endopeptidase concentrations and incubation times used in these reac­
tions were optimized experimentally. Digested products were precipitated on ice 
by adding 10% trichloroacetic acid. Precipitates were pelleted by centrifugation 
at 20,000 � g at 4°C for 10 min and washed with acetone. Precipitates were 
solubilized in 2� sample buffer (4% SDS, 20% glycerol, 125 mM Tris-HCl [pH 
6.8], 10% �-mercaptoethanol, bromophenol blue) and boiled for 5 min. Proteins 
from an equivalent of 250 �l of bacterial supernatant were resolved by electro­
phoresis on an SDS–11% polyacrylamide gel and electrotransferred to a polyvi­
nylidene diﬂuoride membrane by using a semidry transfer apparatus (Bio-Rad 
Laboratories, Hercules, Calif.). PC-PLC was detected by Western immunoblot­
ting. 
Western immunoblotting. Western immunoblot assays were performed as de­
scribed previously (30). Primary antibodies used were afﬁnity-puriﬁed rabbit anti-
PC-PLC (1/5,000) and afﬁnity-puriﬁed rat anti-PC-PLC propeptide (1/1,000). Sec­
ondary antibodies used were alkaline phosphatase-conjugated goat anti-rabbit 
immunoglobulin G (IgG) and anti-rat IgG (1/25,000). 
Generation of anti-propeptide antibody and afﬁnity puriﬁcation. An 18-mer 
peptide (CDEYLQTPAAPHDIDSKL), encompassing three-fourths of the PC­
PLC propeptide (Fig. 1b), was synthesized (Protein Chemistry Laboratory of the 
Medical School of the University of Pennsylvania) and conjugated to keyhole 
limpet hemocyanin. Generation of the rat immune serum was contracted by 
Cocalico Biologicals, Inc. For afﬁnity puriﬁcation of antibodies, the propeptide 
was conjugated to SulfoLink coupling gel (Pierce Biotechnology Inc.), and spe­
ciﬁc antibodies were puriﬁed according to the manufacturer’s instructions. 
Metabolic labeling and immunoprecipitation experiments. For metabolic la­
beling of intracellularly grown bacteria, the mouse macrophage-like cell line J774 
was used and the experiment was performed as described previously (19, 30) with 
minor modiﬁcations. Brieﬂy, at 3 h postinfection, bacterial cell-to-cell spread was 
blocked with cytochalasin D, an inhibitor of actin polymerization, to test specif­
ically for Mpl-mediated processing of PC-PLC and prevent PC-PLC activation by 
a host vacuolar cysteine protease (19). At 4 to 5 h postinfection, cells were 
pulse-labeled for 5 min with [35S]Met and chased for 5 min. When indicated, cells 
were chased for an additional 5 min in nigericin-containing buffer at pH 7.3 or 
6.5. The pulse-chase was performed in the presence of proteasome and host 
protein synthesis inhibitors. Chloramphenicol was also present during the chase. 
Labeled samples were lysed, and bacteria were separated from host cell lysates 
by centrifugation. Bacterial cells were lysed, and PC-PLC or PLCBC was immu­
noprecipitated from host and bacterial cell lysates using afﬁnity-puriﬁed antibod­
ies. PLCBC is a chimera composed of the PC-PLC propeptide and the catalytic 
domain of the Bacillus cereus PC-PLC ortholog (38). Bacterial counts were 
determined in parallel dishes and ranged from 1.5 � 107 to 6 � 107 per sample. 
Equivalent numbers of bacteria were loaded per lane of an SDS–11% polyacryl­
amide gel. Immunoprecipitates were resolved by SDS-PAGE and detected by 
autoradiography with a BioMax Transcreen LE and by phosphorimaging using a 
STORM 860 scanner. Results were analyzed with ImageQuant software (Mo­
lecular Dynamics). 
RESULTS 
Active PC-PLC is generated independently of the propep­
tide. Protein propeptides may function as intramolecular chap­
erones and in some instances are required for a protein to 
reach its native conformation. To test whether the propeptide 
of PC-PLC is required for protein folding, we created a mutant 
in which the prodomain was deleted (plcB�pro) (Fig. 1b). The 
plcB�pro strain was tested for phospholipase activity on egg 
yolk plates and showed a strong zone of opacity, which is 
FIG. 2. Detection of PC-PLC activity. L. monocytogenes wild-type 
strain 10403S and isogenic mutants were grown on LB-G1P-EY plates 
for 36 h. PC-PLC activity was detectable by the formation of a zone of 
opacity in the medium. 
indicative of phospholipid hydrolysis (Fig. 2). Therefore, the 
catalytic domain of PC-PLC can reach native conformation 
independently of the propeptide. In addition, as expected, the 
plcB�pro strain generated active PC-PLC independently of 
Mpl (Fig. 2). 
The zone of PC-PLC activity generated by the plcB�pro 
strain was easily detectable after an 18-h incubation at 37°C, 
whereas that of the wild-type strain appeared after 36 to 48 h 
of incubation. In the wild-type strain, proteolytic activation of 
PC-PLC requires Mpl and a decrease in pH (20). The obser­
vation that the plcB�pro strain showed activity early during 
growth was not surprising, as it bypasses the requirements for 
activation. In addition, this result substantiates that PC-PLC 
activity per se is not dependent on acidic pH (10). 
It is also worth noting that the plcB�pro strain did not show any 
growth defect in broth (data not shown) or on plates (Fig. 2), 
indicating that constitutive PC-PLC activity is not toxic for the 
bacterial cell. Since PC-PLC is capable of hydrolyzing phosphati­
dylglycerol and cardiolipin, two phospholipids present in the cy­
toplasmic membrane of L. monocytogenes (8, 10), these two phos­
pholipids may not be predominant in the outer layer of the 
bacterial cytoplasmic membrane. 
The propeptide of PC-PLC does not prevent native folding 
of the PC-PLC catalytic domain. Translocation across the cell 
wall of gram-positive bacteria is the rate-limiting step for many 
secreted proteins. Protein structure is one of the factors inﬂu­
encing protein translocation, as correct protein folding is a 
prerequisite to efﬁcient translocation across the bacterial cell 
wall (13, 14, 35). For PC-PLC, efﬁcient translocation correlates 
with proteolytic activation, and the propeptide may interfere 
with folding of the catalytic domain, hampering translocation 
of PC-PLC across the cell wall. We performed proteolytic 
digests of the secreted pro and active forms of PC-PLC to 
investigate their structure. Trypsin, chymotrypsin, and glutamyl 
endopeptidase (V8), which are serine peptidases, and the zinc-
dependent peptidase thermolysin were used for proteolytic 
digests. There are over 30 putative sites for each one of these 
peptidases in the pro and active forms of PC-PLC (37). Partial 
proteolysis was observed for the proform of PC-PLC (Fig. 3, 
FIG. 3. PC-PLC proteolytic digests. Bacterial supernatants from 
strains expressing PC-PLC, PC-PLC S51D S53N, PC-PLC�pro, or no 
PC-PLC were subjected to the proteolytic activity of trypsin (T) and 
chymotrypsin (C). Proteolytic digests were analyzed by Western im­
munoblotting with afﬁnity-puriﬁed rabbit anti-PC-PLC (upper panel) 
or rat anti-propeptide (bottom panel) antibodies. Samples incubated 
without proteases were loaded in lanes 1, 4, 7, and 10. The extra band 
migrating below the processed form of PC-PLC in all the trypsin 
digests is due to a nonspeciﬁc reaction with trypsin. Chymotrypsin, 
which migrates slightly below the processed form of PC-PLC, can also 
be seen as a very faint band in lane 12, upper panel. 
upper panel, and data not shown). Trypsin, chymotrypsin, and 
thermolysin digests generated one major product that reacted 
with the afﬁnity-puriﬁed PC-PLC antibody and comigrated 
with the active form of PC-PLC. It was further determined that 
the N terminus of the proform of PC-PLC was being cleaved by 
these three peptidases, as the PC-PLC product generated was 
not recognized by a propeptide-speciﬁc antibody (Fig. 3, bot­
tom panel, and data not shown). The proform of PC-PLC was 
also partially sensitive to proteolysis by glutamyl endopepti­
dase. The product generated comigrated with the active form 
of PC-PLC and did not react with the propeptide-speciﬁc an­
tibody (data not shown). Interestingly, cleavage of PC-PLC 
propeptide by these peptidases did not generate active PC­
PLC, as tested by the egg yolk overlay assay (data not shown). 
According to structural studies on phospholipase C from B. 
cereus, a PC-PLC ortholog, the ﬁrst amino acid residue of the 
PC-PLC catalytic domain (W52) would be an important zinc-
coordinating residue (12). Perhaps speciﬁc cleavage between 
S51 and W52 is essential to generate an active enzyme. 
The active form of PC-PLC (PC-PLC�pro) was completely 
resistant to proteolysis by all four peptidases and the protein 
maintained its full activity, indicating that none of the putative 
cleavage sites are accessible on active PC-PLC (Fig. 3, upper 
panel, and data not shown). Overall, these results suggest that 
the catalytic domain of PC-PLC reaches native conformation 
before cleavage of the propeptide, except for a small region 
encompassing amino acid residues ﬂanking the propeptide 
cleavage site, which was accessible to proteolysis. 
Efﬁcient translocation of PC-PLC across the bacterial cell 
wall is independent of propeptide cleavage but dependent of 
Mpl. Rapid translocation of PC-PLC across the bacterial cell 
wall occurs in response to a decrease in pH and correlates with 
processing of the PC-PLC propeptide in an Mpl-dependent 
manner (20, 30). To investigate the speciﬁc role of the propep­
tide in PC-PLC translocation across the cell wall, we created a 
PC-PLC cleavage site mutant. The cleavage site between the 
pro and catalytic domains of PC-PLC is K49-L50-S51//W52­
TABLE 3. Quantiﬁcation of PC-PLC translocation across the 
bacterial cell wall 
Translocation at pHa: 
Strain genotype 
7.3 6.5 
Wild type 7.9 � 0.5b 73.8 � 2.9*c 
plcB S51D S53N 9.4 (7.2, 11.6) 79.2 (72.7, 85.8) 
�mpl plcB S51D S53N 11.0 (8.0, 14.0) 18.6 (14.0, 23.3) 
plcB�pro 64.4 � 9.3 82.8 � 7.7 
�mpl 6.5 � 4.5 15.1 � 3.6 
�mpl plcB�pro 55.9 � 22.0 73.5 � 12.6 
a pH at which the pulse-labeled infected cells were chased in the presence of 
nigericin as described in Materials and Methods. 
b Mean percent � standard deviation of PC-PLC immunoprecipitated from 
lysates of infected cells, determined by quantitative analysis of phosphorscans 
from three independent experiments, except for the cleavage site mutants for 
which two independent experiments were performed. Results from each individ­
ual experiment performed with the cleavage site mutants are shown in paren­
theses. 
c P values (*, P � 0.0001) for comparison of PC-PLC translocation at either 
pH 7.3 or 6.5 by two-sample t test. Statistical analyses were not performed on 
samples with less than three replicates. 
S53-A54 (Fig. 1b). The catalytic domain of the B. cereus or­
tholog also starts with WSA, and the crystal structure indicates 
that the tryptophan residue is one of the nine zinc-coordinating 
residues (12). Site-directed mutagenesis was used to mutate 
the last amino acid residue of the propeptide (S51) and the 
second amino acid residue of the catalytic domain (S53). The 
resulting mutant, PC-PLC S51D S53N (Fig. 1b), was negative 
for PC-PLC activity when grown on egg yolk semisolid medium 
(Fig. 2), although a small amount of processed PC-PLC was 
detectable from infected cells (see below). PC-PLC S51D 
S53N behaved similarly to PC-PLC when subjected to trypsin, 
chymotrypsin, thermolysin, and glutamyl endopeptidase activ­
ities, suggesting that the double mutation did not affect PC­
PLC native conformation (Fig. 3 and data not shown). 
Pulse-chase experiments were performed to follow translo­
cation of PC-PLC S51D S53N across the bacterial cell wall as 
a function of pH. Infected cells were pulse-labeled with 
[35S]Met and then chased in a potassium-based buffer at either 
pH 7.3 or 6.5 in the presence of nigericin to equilibrate host 
intracellular pH (20). As usual, the labeling experiment was 
performed in the presence of a proteasome inhibitor to stabi­
lize PC-PLC, as PC-PLC secreted in the cytosol of infected 
cells is rapidly degraded by the proteasome (19). In addition, 
an inhibitor of bacterial cell-to-cell spread was used to prevent 
PC-PLC activation by a host vacuolar cysteine protease (19). 
Similar to wild-type PC-PLC, PC-PLC S51D S53N remained 
largely bacteria-associated at pH 7.3 (9.4% translocated) (Ta­
ble 3 and Fig. 4). At pH 6.5, approximately 29.3% of secreted 
PC-PLC S51D S53N was processed, as opposed to 90.2% for 
PC-PLC (Fig. 4, upper panel, lanes 13 and 10). Nevertheless, 
under these conditions, PC-PLC S51D S53N was translocated 
as efﬁciently as PC-PLC (79.2% translocation for PC-PLC 
S51D S53N versus 73.8% for PC-PLC). This result indicates 
that a decrease in pH is sufﬁcient for efﬁcient translocation of 
the proform of PC-PLC S51D S53N across the bacterial cell 
wall. 
Next, to investigate the speciﬁc role of Mpl in PC-PLC 
translocation across the cell wall, we transferred the plcB S51D 
S53N mutation into a �mpl strain and evaluated the pH-de-
FIG. 4. Cell wall translocation of PC-PLC and PC-PLC S51D S53N 
during intracellular infection. Bacteria grown in J774 cells were pulse-
labeled for 5 min and chased for 5 min at 37°C as described in Mate­
rials and Methods. When indicated, samples were treated for an ad­
ditional 5 min with nigericin in buffer of pH 7.3 or 6.5. PC-PLC was 
immunoprecipitated from bacterial lysates (bacteria-associated) and 
host cell lysates (secreted), and samples were fractionated by SDS­
PAGE. The gel was scanned with a phosphorimager. Proform and 
processed forms of PC-PLC migrated as indicated on the left side of 
the ﬁgure. 
pendent behavior of this mutant in the absence of Mpl. In the 
absence of Mpl, PC-PLC S51D S53N remained entirely in its 
proform and largely bacterium-associated at either pH: 11.0 
and 18.6% translocation at pH 7.3 and 6.5, respectively (Table 
3 and Fig. 4, lower panel). Overall, these results reveal that 
Mpl controls PC-PLC translocation across the bacterial cell 
wall by a mechanism that is pH sensitive but independent of its 
role in the proteolytic activation of PC-PLC. 
PC-PLC�pro is efﬁciently translocated across the bacterial 
cell wall at physiological pH. To investigate the speciﬁc role of 
the PC-PLC propeptide in protein translocation, the intracellular 
behavior of PC-PLC�pro was evaluated as a function of pH and 
Mpl. At pH 7.3, PC-PLC remained largely bacterium-associated 
(7.9% translocated), whereas 64.4% of PC-PLC�pro was immu­
noprecipitated from the host cell lysate (Table 3 and Fig. 5, upper 
panel). At pH 6.5, PC-PLC was activated and translocation in­
creased by 9.3-fold (73.8% translocated), whereas PC-PLC�pro 
translocation only increased by 1.3-fold (82.8% translocated) (Ta­
ble 3 and Fig. 5, upper panel). These results indicate that in the 
absence of a propeptide, translocation of PC-PLC across the 
bacterial cell wall is relatively insensitive to pH. 
Next, the requirement for Mpl for translocation of PC-
PLC�pro across the bacterial cell wall was evaluated. At pH 
7.3 and in the absence of Mpl, PC-PLC remained largely bac­
terium-associated (6.5% translocated), whereas 55.9% of PC-
PLC�pro was immunoprecipitated from the host cell lysate 
(Table 3 and Fig. 5, lower panel). At pH 6.5 and in the absence 
of Mpl, PC-PLC remained largely bacteria-associated (15.1% 
translocated), whereas 73.5% of PC-PLC�pro was immuno­
precipitated from the host cell lysate (Table 3 and Fig. 5, lower 
panel). Although the small changes in protein translocation at 
FIG. 5. Cell wall translocation of PC-PLC and PC-PLC�pro during 
intracellular infection. The experiment was performed as described in 
the legend of Fig. 4. 
pH 6.5 were reproducible, these changes were not statistically 
signiﬁcant. These results indicate that, in the absence of a 
propeptide, translocation of PC-PLC across the bacterial cell 
wall is no longer regulated by Mpl. 
Immunoprecipitates from cells infected with the plcB�pro 
strain revealed the presence of secreted protein species larger 
than monomeric PC-PLC (Fig. 5, upper panel, lanes 11 to 13, 
and lower panel, lanes 10 to 12). These protein species were 
not detected by Western immunoblotting of the supernatant of 
bacterial cultures. The identity of these large protein species is 
unknown. 
The propeptide of PC-PLC does not regulate translocation 
of a chimera across the bacterial cell wall. Results from the 
previous experiment suggest that the PC-PLC propeptide con­
tributes to the formation of a bacterium-associated pool of 
PC-PLC. To determine if the catalytic domain inﬂuences 
propeptide function in protein translocation across the bacte­
rial cell wall, the behavior of a chimera was evaluated. For 
these experiments, we used an isogenic 10403S derivative ex­
pressing a chimera composed of the PC-PLC propeptide and 
the catalytic domain of the B. cereus PC-PLC ortholog, PLCBC 
(38). The catalytic domains of PC-PLC and PLCBC are nearly 
40% identical at the amino acid level. Like PC-PLC, the chi­
mera is processed by Mpl in a pH-dependent manner, gener­
ating an active enzyme (reference 38 and data not shown). In 
a previous study, this chimera was shown to be secreted at a 
higher concentration than PC-PLC in infected J774 cells (38). 
However, it was not established whether the difference in pro­
tein concentration was due to an increase in the total amount 
of protein or to an increase in the rate of protein translocation 
across the bacterial cell wall. In the present study, we evaluated 
the behavior of PLCBC in infected J774 cells maintained at 
physiological pH. Afﬁnity-puriﬁed antibodies speciﬁc to PC­
PLC and PLCBC were used to immunoprecipitate these pro­
teins from bacterial and host cell lysates, respectively. We 
observed that PC-PLC and PLCBC were present in similar 
FIG. 6. Cell wall translocation of PC-PLC and the chimera PLCBC 
during intracellular infection. The experiment was performed as de­
scribed in the legend of Fig. 4, except that the samples were not chased 
with nigericin in buffer pH 7.3 or 6.5. 
amounts in the combined cell wall-associated and secreted 
fractions (Fig. 6). However, at physiological pH, the proform 
of the chimera was more efﬁciently translocated across the 
bacterial cell wall of L. monocytogenes than that of PC-PLC 
(62% translocation for PLCBC and 5% for PC-PLC) (Fig. 6). 
These results indicate that the PC-PLC propeptide does not 
have an intrinsic ability to regulate protein translocation across 
the bacterial cell wall, but rather the ability of the PC-PLC 
propeptide to regulate protein translocation is inﬂuenced by 
the nature of the protein to which it is bound. 
DISCUSSION 
L. monocytogenes has the remarkable ability to maintain a 
pool of PC-PLC at its membrane-cell wall interface and to 
promptly release a bolus of active PC-PLC within vacuoles 
formed in the process of cell-to-cell spread (19, 20, 30). Efﬁ­
cient translocation of PC-PLC across the bacterial cell wall 
occurs upon a decrease in pH and correlates with the proteo­
lytic cleavage of an N-terminal propeptide in an Mpl-depen­
dent manner. In the absence of Mpl, bacteria-associated PC­
PLC remains in its proform and translocation across the 
bacterial cell wall is very inefﬁcient independent of pH. In this 
study, we investigated the role of the propeptide and of Mpl in 
the mechanism regulating translocation of PC-PLC across the 
bacterial cell wall. Our results revealed that Mpl regulates 
PC-PLC translocation across the bacterial cell wall in a manner 
that is dependent on the presence of the propeptide, but in­
dependent of propeptide cleavage. In addition, similar to Mpl­
mediated cleavage of the PC-PLC propeptide, Mpl-mediated 
translocation of PC-PLC across the bacterial cell wall is regu­
lated by pH. Therefore, both Mpl functions are pH sensitive 
and dependent on the PC-PLC propeptide. 
A cleavage site mutant (PC-PLC S51D S53N) was created to 
determine whether Mpl possesses a biological function that is 
independent of cleavage of the PC-PLC propeptide. PC-PLC 
S51D S53N was processed upon a decrease in intracellular pH, 
although to a much lesser extend than wild-type PC-PLC. 
However, in absence of Mpl, processing of PC-PLC S51D 
S53N was undetectable. These results suggest that Mpl is re­
sponsible for the proteolytic activation of PC-PLC S51D S53N, 
even though D and N are not generally favorable for protease 
activity of the Mpl family (23). 
Proteolytic digests of PC-PLC and PC-PLC S51D S53N sug­
gested that the proteins are structurally identical. Similarly to 
PC-PLC, PC-PLC S51D S53N remained largely bacteria-asso­
ciated at physiological pH. At acid pH, PC-PLC S51D S53N 
was as efﬁciently translocated across the bacterial cell wall as 
PC-PLC, even though 70% of the translocated mutant protein 
was in its proform. These results indicate that Mpl carries a 
pH-sensitive function that is independent of cleavage of the 
PC-PLC propeptide and that contributes to the regulation of 
PC-PLC translocation across the bacterial cell wall. 
A prodomain deletion mutant was created to address the 
role of the propeptide in translocation of PC-PLC across the 
bacterial cell wall. This mutant makes constitutively active PC­
PLC, indicating that the PC-PLC propeptide is not required 
for folding of the mature protein, suggesting that it is a class II 
propeptide (27). Class II propeptides are associated with a 
variety of biological functions, including intermolecular inter­
actions, sorting, and secretion. Remarkably, PC-PLC�pro was 
very efﬁciently translocated across the bacterial cell wall at 
physiological pH independent of Mpl, a behavior that is con­
trary to that of PC-PLC. This result suggests that the PC-PLC 
propeptide is a regulatory element, as the propeptide enables 
the formation of a pool of PC-PLC at the membrane-cell wall 
interface and prevents premature PC-PLC activity. However, 
the propeptide does not regulate translocation of the PLCBC 
chimera, even though it regulates its activity (38). It seems that 
the sorting function of the propeptide is inﬂuenced by the 
nature of the protein to which it is bound. 
Efﬁcient translocation of PC-PLC across the bacterial cell 
wall and cleavage of the PC-PLC propeptide are both medi­
ated by Mpl upon a decrease in pH. Mpl is active at pH values 
ranging from 5 to 9 (7), suggesting that Mpl proteolytic activity 
per se is unlikely to be the pH-limiting factor. However, similar 
to PC-PLC, Mpl is made as a proenzyme whose activation 
requires cleavage of an N-terminal propeptide, so proteolytic 
activation of Mpl could be the pH-sensitive step. It is possible 
that Mpl functions as a chaperone in its proform, preventing 
PC-PLC to translocate across the bacterial cell wall and per­
haps contributing to PC-PLC folding. DegP, also known as 
HtrA, is an example of a protein carrying a dual function as a 
chaperone and a protease (2, 15, 31). If Mpl contributes to 
PC-PLC folding, PC-PLC translocation across the bacterial 
cell wall would be impaired in the absence of Mpl as a result of 
PC-PLC misfolding. Alternatively, Mpl may target molecules 
other than PC-PLC whose processing or degradation is the 
prerequisite for the efﬁcient translocation of PC-PLC across 
the cell wall. Future studies will assess the requirement for Mpl 
proteolytic activity in the mechanism regulating PC-PLC trans­
location across the bacterial cell wall. 
In conclusion, results from this study and previous studies 
indicate that Mpl contributes to the regulation of PC-PLC 
activity by two independent mechanisms, both of which are pH 
sensitive. First, Mpl regulates cell wall translocation of PC­
PLC. Second, Mpl regulates the proteolytic activation of PC­
PLC. Importantly, both functions require the presence of the 
PC-PLC propeptide, because if the propeptide is absent, then 
PC-PLC translocation and activity are no longer regulated by 
Mpl and pH. These studies emphasize the complexity of pro­
tein translocation across the cell wall of gram-positive bacteria 
and the ability of a bacterial pathogen to regulate in a spatial 
and temporal manner the activity of an important virulence 
factor. 
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